Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
January 31, 2026 0.0041M
October 31, 2025 0.0043M
July 31, 2025 0.0045M
April 30, 2025 0.0045M
January 31, 2025 0.0061M
October 31, 2024 0.0091M
July 31, 2024 0.0123M
April 30, 2024 0.0107M
January 31, 2024 0.0115M
October 31, 2023 0.012M
July 31, 2023 0.0123M
April 30, 2023 0.0442M
January 31, 2023 0.0135M
October 31, 2022 0.0134M
July 31, 2022 0.0171M
April 30, 2022 0.0184M
January 31, 2022 0.0328M
October 31, 2021 0.0305M
July 31, 2021 0.0634M
April 30, 2021 0.1213M
January 31, 2021 0.1266M
October 31, 2020 0.1299M
July 31, 2020 0.0043M
April 30, 2020 0.00
January 31, 2020 0.00
Date Value
October 31, 2019 0.00
July 31, 2019
April 30, 2019
January 31, 2019
October 31, 2018
July 31, 2018
April 30, 2018
January 31, 2018
October 31, 2017
July 31, 2017 0.4195M
April 30, 2017 3.606M
January 31, 2017 3.605M
October 31, 2016 0.5987M
July 31, 2016 0.5986M
April 30, 2016 0.6075M
January 31, 2016 0.5983M
October 31, 2015 0.5973M
July 31, 2015 0.5974M
April 30, 2015 0.5969M
January 31, 2015 0.6029M
October 31, 2014 0.7635M
July 31, 2014 0.3761M
April 30, 2014 1.806M
January 31, 2014 2.030M
October 31, 2013 2.050M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 172.69M
Amgen, Inc. 95.64B
Altimmune, Inc. 527.21M
AnaptysBio, Inc. 346.01M
Aligos Therapeutics, Inc. 66.33M

Total Assets (Quarterly) Related Metrics